0001225208-21-011037.txt : 20210802 0001225208-21-011037.hdr.sgml : 20210802 20210802213524 ACCESSION NUMBER: 0001225208-21-011037 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210802 FILED AS OF DATE: 20210802 DATE AS OF CHANGE: 20210802 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Szyman Catherine M. CENTRAL INDEX KEY: 0001438538 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15525 FILM NUMBER: 211137657 MAIL ADDRESS: STREET 1: C/O EDWARDS LIFESCIENCES CORPORATION STREET 2: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 FORMER NAME: FORMER CONFORMED NAME: Szyman Catherine M DATE OF NAME CHANGE: 20080625 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edwards Lifesciences Corp CENTRAL INDEX KEY: 0001099800 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 364316614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9492502500 MAIL ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP. DATE OF NAME CHANGE: 20090225 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP DATE OF NAME CHANGE: 20000203 FORMER COMPANY: FORMER CONFORMED NAME: CVG CONTROLLED INC DATE OF NAME CHANGE: 19991126 4 1 doc4.xml X0306 4 2021-08-02 0001099800 Edwards Lifesciences Corp EW 0001438538 Szyman Catherine M. ONE EDWARDS WAY IRVINE CA 92614 1 CVP, Critical Care Common Stock 2021-08-02 4 M 0 15000.0000 21.7600 A 42758.9088 D Common Stock 2021-08-02 4 S 0 15000.0000 113.5269 D 27758.9088 D Employee Stock Option (Right to Acquire) 21.7600 2021-08-02 4 M 0 15000.0000 0.0000 D 2016-05-14 2022-05-13 Common Stock 15000.0000 132882.0000 D This transaction was executed in multiple trades at prices ranging from $113.4450 to $113.7500. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This Form 4 includes quarterly acquisition of shares under the Issuer's Employee Stock Purchase Plan. Linda J. Park, Attorney-in-Fact 2021-08-02